Home Products Axitinib
CAS NO: 319460-85-0
Molecular Formula: C22H18N4OS
Molecular Weight: 386.47
Purity: 99%
Solubility: In DMSO
Storage: −20°C 2 years
Availability and Price
100MG/$100 In-stock If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
200MG/150 In-stock
500MG/$300 In-stock Order       Order Infomation
1G/$600 In-stock
Shipping and handling fee USD40
Free delivery is qualified when the total value of your order exceeds 500USD
Remarks: Axitinib exhibits primary inhibition to orthotopically transplanted models such as M24met (melanoma), HCT-116 (colorectal cancer), and SN12C (renal cell carcinoma). [1] Axitinib delays the tumor growth with 11.4 days compared to the controls (p.o. 30 mg/kg) and decreases the Mean Vessels Density (MVD) to 21, compared to 49 in controls, in IGR-N91 flank xenografts. [2] Axitinib significantly inhibits growth and disrupts tumor microvasculature in BT474 breast cancer model at 10C100 mg/kg. [3] Axitinib has shown single-agent activity in variable tumors, including renal cell carcinoma, thyroid cancer, non-small cell lung cancer, and melanoma.

Quality Control

Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Related Products
C-Kit Inhibitors

None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.

Our products are for research use only, not for human use.
Homepage | About Us | Products | News&Events | Custom Synthesis | Order Infomation | Contact Us
Friendly link: molbase   Copyright © Taizhou Crene Biotechnology Co.,Ltd. 技术支持:趋势科技